Chronic/Functional Digestive Symptoms Evaluation Note

A comprehensive evaluation template for chronic functional GI symptoms including IBS, bloating, functional constipation, and dyspepsia. Features structured alarm feature screening, staged diagnostic testing strategy alig…

Document Type

clinical note / Diagnostic Evaluation Note

Specialties

Functional MedicineNaturopathic Doctor
Created by Augustun

Template Preview

Date/Time: [Encounter date and time]

Clinician: [Clinician name, credentials]

Clinic/Location: [Clinic or location]

Encounter Type: [new / established]

Primary Historian: [patient / caregiver / chart review / combination]; Interpreter: [yes (language) / no / not needed]

(Provenance labeling: Throughout this note, label information as "per patient report," "per outside record (source/date)," or "reviewed in chart" to clarify provenance.)

Chief Concern

[Primary symptom(s) in patient language with duration] (One concise line; include a brief direct quote if it adds clarity.)

History of Present Illness

[Brief narrative summary of symptom trajectory] (Summarize onset, evolution, phenotype, severity, and pattern to support a positive diagnostic approach for functional GI disorders.)

  • Timeline and evolution: [Symptom onset (date or best approximation)]; [Inciting events: recent infection, antibiotics, travel, surgery, major stressor]; [Progression: stable / worsening / improving; episodic / continuous]; [Baseline bowel pattern prior to current illness]. (If onset is unclear, provide the best available anchor.)
  • Symptom characterization:
    • Abdominal pain: [Location]; [Quality]; [Intensity 0–10]; [Frequency/pattern]; [Relation to defecation: better / worse / unchanged]; [Relation to meals]; [Nocturnal occurrence: yes / no].
    • Bloating and distention: [Perceived bloating vs visible distention]; [Timing/triggers: post-prandial / evening / specific foods]; [Belching pattern]; [Flatulence pattern].
    • Bowel habit: [Stool frequency]; [Bristol Stool Scale types]; [Urgency]; [Tenesmus]; [Incomplete evacuation]; [Incontinence]; [Nocturnal stools: yes / no]. (If constipation: [Straining]; [Sensation of blockage]; [Digital maneuvers].)
    • Upper GI symptoms (if relevant): [Nausea/vomiting]; [Early satiety]; [Post-prandial fullness]; [Heartburn/regurgitation]; [Dysphagia].
    • Systemic symptoms: [Hematochezia/melena]; [Mucus]; [Fever]; [Unintentional weight change]; [Extraintestinal features if IBD or celiac considered: joints, rash, oral ulcers].
  • Dietary pattern and triggers: [Typical intake pattern]; [Fiber and hydration]; [Caffeine/alcohol/carbonated beverages]; [Dairy and gluten exposure]; [High-FODMAP patterns]; [Trigger reproducibility]. [Elimination diets tried: what, duration, adherence, response, downsides]. [Nutrition risk flags: restrictive intake, weight loss, fear of eating, limited variety]. (If diet history not obtained, state: "Diet history not assessed today.")
  • Medications and substances affecting GI: [Laxatives]; [Antidiarrheals]; [Acid suppressants]; [Antispasmodics]; [Antibiotics]; [Metformin]; [GLP-1 agents]; [NSAIDs]; [Iron]; [Magnesium]; [Opioids]; [Psychotropics]; [Supplements/probiotics/peppermint]; [Cannabis]. (Include dose, frequency, start/stop dates, and patient-reported effects when available.)
  • Prior evaluations and treatments: (List chronologically; separate verified records from patient report.)
    • Prior testing: [Test type, date, result, source: patient report / outside record / reviewed in chart].
    • Prior diagnoses communicated to patient: [Diagnosis and by whom].
    • Prior treatments: [Name, dose, duration, adherence (per patient report), response, adverse effects].
    • Diet/behavioral therapy trials: [Type, duration, adherence, response].
  • Functional impact: [Work/school impairment]; [Sleep disruption]; [Activity avoidance]; [Patient priorities/goals for this evaluation].

Alarm Features Screen

(Structured checklist; select a status for each item. Do not default to "absent" if not specifically asked.)

  • GI bleeding (hematochezia, melena): [present / absent / not assessed] [Details if present]
  • Iron-deficiency anemia or anemia concern: [present / absent / not assessed] [Details if present]
  • Unintentional weight loss: [present / absent / not assessed] [If present, quantify amount and timeframe]
  • Persistent vomiting or progressive dysphagia: [present / absent / not assessed] [Details if present]
  • Nocturnal symptoms (pain or diarrhea waking from sleep): [present / absent / not assessed]
  • Fever or systemic inflammatory signs: [present / absent / not assessed]
  • Family history (first-degree relative): colorectal cancer, IBD, or celiac: [present / absent / not assessed] [Specify condition and relative/age if present]
  • New symptom onset at age ≥45: [present / absent / not assessed]
  • Immunosuppression, cancer history, or recent high-risk travel: [present / absent / not assessed] [Details if present]

Past Medical History

  • GI history: [Prior diagnoses: IBS, GERD, IBD, celiac, peptic ulcer]; [GI surgeries: cholecystectomy, bariatric, other]; [Prior infectious gastroenteritis or C. difficile].
  • Relevant non-GI conditions: [Thyroid disease]; [Diabetes]; [Connective tissue disorders]; [Neurologic conditions]; [Pelvic floor disorders]; [Gynecologic history if pelvic symptoms overlap].
  • Behavioral health context: [Anxiety]; [Depression]; [Significant stressors]; [Sleep quality]; [Prior psychotherapy or openness to brain-gut behavioral approaches]. (Document observed affect neutrally; do not infer diagnoses without patient report or documentation.)
  • Allergies: [Drug/food/environmental allergies and reactions].
  • Current medications: [Medication name, dose, frequency]. (Per patient report vs reviewed in chart.)

Family History

  • Colorectal cancer or polyps: [Relative and age at diagnosis]
  • Inflammatory bowel disease: [Relative and age]
  • Celiac disease: [Relative and age]
  • Other relevant hereditary conditions: [Details]

Social History

  • Diet access and ability to follow diet trials: [Adequacy / barriers]
  • Travel or exposure history (if diarrhea): [Details]
  • Tobacco use: [Type, amount, duration]
  • Alcohol use: [Amount, pattern]
  • Occupation constraints (bathroom access): [Details]
  • Exercise level: [Details]

Review of Systems

(Include only systems actually reviewed and relevant to the differential. Omit autopopulated negative lists.)

  • [GI-related ROS findings]
  • [Constitutional, endocrine, rheumatologic, neurologic, dermatologic, or other systems only if specifically reviewed]

Physical Examination

  • Vitals: [BP]; [HR]; [Temp]; [BMI]; [Weight today]; [Weight trend if available].
  • General: [Appearance]; [Hydration status]; [Nutritional state].
  • Abdomen: [Inspection]; [Auscultation if performed]; [Palpation: tenderness location, masses, guarding, rebound].
  • Additional findings: [Skin or oral findings if celiac/IBD considered]; [Rectal exam findings if performed]. (If rectal exam deferred: [Rationale].)

Data Reviewed

(Data verified or obtained today; include dates and sources. Separate from patient-reported prior history documented in HPI.)

  • Labs: [CBC, CMP, inflammatory markers, celiac serologies, thyroid function, other] (Date, result, source for each.)
  • Stool studies: [Calprotectin, pathogens, ova and parasites, other] (Date, result, source.)
  • Imaging: [Modality, date, key findings, source].
  • Endoscopy: [Dates, key findings, pathology results; note if outside report vs patient report only].
  • Prior notes reviewed: [Specialist consultations or hospital records; dates; key takeaways].

Assessment

Summary: [Age, sex] with [dominant symptom cluster] for [duration]. Alarm features [present (specify) / absent as assessed]. Prior workup [summary]. Working impression: [diagnostic impression].

  • [Problem 1]: [Most likely diagnosis] — [Supporting rationale].
    • Key differentials: [Prioritized differentials relevant to phenotype].
    • Alarm features and implications: [Impact on testing/urgency].
    • Prior workup adequacy: [Sufficient / gaps identified].
  • [Problem 2]: [Diagnosis or symptom complex]. (Include additional problems only if discussed.)

(For functional GI disorder impressions, document the symptom pattern supporting the diagnosis, alarm feature status, and the planned limited targeted exclusion strategy.)

Differential framework: [Inflammatory (IBD, microscopic colitis); Malabsorptive (celiac, carbohydrate intolerance); Infectious; Medication-related; Motility/functional/DGBI; Bile acid diarrhea; SIBO if risk factors; Structural/neoplastic based on age and alarm features; Extra-GI mimics]. (Include categories relevant to this patient's presentation.)

Plan

  • Safety and return precautions: [Urgent actions if alarm features present]; [Return-to-care triggers: GI bleeding, dehydration, severe vomiting]; [If escalation deferred, document rationale].
  • Diagnostic testing (staged approach):
    • Stage 0 (verification): [Consolidate prior workup; obtain outside records to avoid duplication].
    • Stage 1 (targeted initial testing): [Tests aligned to phenotype and risk; state purpose and how results will change management].
    • Stage 2 (advanced testing): [Reserved for alarm features, abnormal initial results, or refractory course; specify triggers for escalation].
    • Testing deferral (if applicable): [Rationale: adequate prior workup, no alarm features, plan to trial intervention and reassess].
  • Diet interventions: [Approach: fiber optimization, low-FODMAP trial, lactose restriction, other]; [Duration]; [Reintroduction plan]; [Referral to GI dietitian if restrictive diet or nutrition risk flags]; [Note if avoiding overly restrictive diet due to risk].
  • Brain-gut and behavioral interventions: [Education provided using validating language about gut-brain interaction]; [Referral options considered or placed: gut-directed psychotherapy, CBT, hypnotherapy, diaphragmatic breathing]; [Pelvic floor physical therapy if dyssynergia suspected].
  • Pharmacotherapy: (For each medication) [Medication name]; [Indication/symptom targeted]; [Dose]; [Planned duration]; [Key adverse effects reviewed]; [Stop rules if no benefit].
  • Tracking plan: [1–3 objective metrics aligned to chief concern: stool frequency and Bristol types, pain severity/frequency, bloating severity, trigger log]; [Tracking frequency]; [How/when data will be reviewed].
  • Follow-up: [Timeframe tied to intervention (e.g., 4–8 weeks)]; [Criteria for improvement vs failure]; [Next-step contingencies].
  • Orders placed today: [Labs]; [Stool studies]; [Imaging]; [Procedures]; [Referrals: dietitian, pelvic floor PT, behavioral health]; [Patient education provided].

(Missing information handling: If information is unavailable, include a clarifying placeholder such as "date unknown per patient report" rather than leaving ambiguity. Omit entire sections that are not applicable to this encounter.)

Want to use this template?

Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.